Article
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosis
2024-02-10
Abstract excerpt
<h4>Introduction</h4> Multiple sclerosis (MS) is the most common inflammatory neurodegenerative disease of the central nervous system (CNS) in young adults and results in progressive neurological defects. The relapsing-remitting phenotype (RRMS) is the most common disease course in MS and may progress to the progressive form (PPMS). <h4>Objectives</h4> There is a gap in knowledge regarding whether the relapsing...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Cytokine Signaling Pathways and Interactions
- Hereditary Neurological Disorders
- Long-Term Effects of COVID-19
- Metabolomics and Mass Spectrometry Studies
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Pharmacological Effects of Natural Compounds
Identifiers and source
- Literature Corpus work
- 0f02fde3-7a66-53e1-afa8-fee1e6950698
- DOI
- 10.1101/2024.02.07.579252
